$STZ

Constellation Brands misses FY27 outlook, acquires ready-to-drink SpikedAde

Constellation Brands STZ reported Q2 earnings beat with $2.63B sales and $3.74 EPS, but missed FY27 guidance ($11.20-$11.90 vs. $11.82 prior). Beer depletions fell 0.6%, while wine sales rose 17%. The company acquired SpikedAde for $75M-$353M. Shares fell in after-hours trading.

Original reporting
Published Oct 6, 2026, 8:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 9:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Constellation Brands misses FY27 outlook, acquires ready-to-drink SpikedAde — source image
Decision brief

The 30-second read

$STZBearishHigh
01

Why it matters

The guidance shortfall is likely to trigger a sell‑off, while the acquisition adds modest growth potential.

02

Market read

Guidance miss and acquisition together create a near‑term downside catalyst for STZ.

03

What to watch

Cost‑saving initiatives and tariff recovery may mitigate earnings pressure.

Relevance 8/10Novelty 8/10Timing: after-hours today

Background

Constellation Brands reported a Q2 beat but missed full‑year EPS guidance and disclosed a $75M purchase of SpikedAde with up to $278M contingent consideration.

Company-level read

Ticker impact

$STZBearishHigh confidence
Context

Constellation Brands missed its FY27 EPS outlook, forecasting $11.20‑$11.90 versus $11.71 consensus, and announced a $75M acquisition of SpikedAde.

Expected impact

downward pressure as investors price in lower earnings expectations

Evidence & confidence

The new FY27 EPS range is below analyst estimates, and the acquisition adds modest cost without clear near‑term earnings boost.

Market effects

Beer, wine and spirits sector may see broader scrutiny of guidance trends.

U.S. consumer discretionary sentiment could soften.

Limited to investors tracking beverage conglomerates.

Counterpoint

The acquisition could position Constellation in the fast‑growing RTD segment, offering upside if execution exceeds expectations.

Key entities

  • Constellation Brands

    U.S. beverage company (ticker STZ) reporting earnings and acquisition.

  • SpikedAde

    Spirit‑based ready‑to‑drink brand being acquired for $75M.

Related articles

$STZHigh

STZ Stock Falls As Modelo And Corona Lose Volume, Full-Year Profit Outlook Holds

Constellation Brands (STZ) reaffirmed its fiscal 2027 earnings guidance of $11.20 to $11.90 per share, with organic net sales and beer net sales expected to range from -1% to +1%. The company also announced the acquisition of SpikedAde for $75 million, with potential earnouts up to $278 million. STZ stock has fallen 16% year-to-date, despite positive retail sentiment on Stocktwits.

$STZMedAI 8/10

Constellation Brands (STZ) Q2 Beats Estimates but Full-Year EPS

Constellation Brands (STZ) reported Q2 earnings of $3.74 per share on $2.63B revenue, beating estimates. The company lowered full-year EPS guidance to $11.20-$11.90, below market expectations. STZ offers a 3.66% dividend yield with a 38% payout ratio and 8.4% 3-year growth. GuruFocus rates STZ undervalued with a GF Score of 59/100, noting strong profitability but weak momentum. Institutional investors show cautious sentiment.

$STZMedAI 8/10

Constellation Brands buys RTD start-up SpikedAde

Constellation Brands acquired a 100% stake in SpikedAde, a vodka-based RTD brand, for $75m, with up to $278m in performance-based payments. SpikedAde, founded in 2024, has a presence in the eastern US. Constellation plans to expand its distribution using its marketing and sales capabilities.

$STZHighAI 8/10

Constellation Brands (STZ) Q2 Earnings Beat Supports Dividend Su

Constellation Brands (STZ) reported Q2 earnings with Non-GAAP EPS of $3.74, beating estimates by $0.19, and revenue of $2.63B, surpassing projections by $90M. The company maintains a 3.66% dividend yield with a 38% payout ratio and 8.4% 3-year dividend growth. STZ's GF Score is 59/100, indicating moderate financial health. Institutional activity is mixed, with some gurus trimming positions while others add.